Page last updated: 2024-09-03

pd 135158 and 3,4-dihydroxyphenylacetic acid

pd 135158 has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies

Compound Research Comparison

Studies
(pd 135158)
Trials
(pd 135158)
Recent Studies (post-2010)
(pd 135158)
Studies
(3,4-dihydroxyphenylacetic acid)
Trials
(3,4-dihydroxyphenylacetic acid)
Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid)
51005,41038591

Protein Interaction Comparison

ProteinTaxonomypd 135158 (IC50)3,4-dihydroxyphenylacetic acid (IC50)
intestinal alkaline phosphatase precursorMus musculus (house mouse)4.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukamauchi, F; Kusakabe, M; Mataga, N; Wang, YJ1

Other Studies

1 other study(ies) available for pd 135158 and 3,4-dihydroxyphenylacetic acid

ArticleYear
Effects of cholecystokinin-B receptor antagonist on dopamine system in tenascin mutant mice.
    Neuroreport, 1997, Dec-22, Volume: 8, Issue:18

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Hyperkinesis; Indoles; Meglumine; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Proglumide; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Synaptic Transmission; Tenascin; Tyrosine 3-Monooxygenase

1997